A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Plasma discharge in the ASDEX Upgrade fusion device. The plasma edge is guided to the tungsten divertor plates at the bottom. (Photographic resolution limited by performance of the CCD camera used.) ...

NEW YORK, NY, USA I April 01, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO®, the ...

Because of the higher conservation of RSV Fusion (F) protein than the glycoprotein (G) across RSV strains and serotypes, the majority of vaccine candidates targets to viral fusion protein (F) rather ...

We hypothesized that the AAV capsid, which has naturally evolved to overcome many of these barriers, could be repurposed as a protein delivery vehicle. Supporting this hypothesis, our previous domain ...

Results: Pulmonary immunization with CL413-adjuvanted VLPs induced robust nasal IgA responses against the RSV F and G proteins, which was not observed for the other adjuvant combinations. CL413 also ...

A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during ...

The Big Fat Surprise' author Nina Teicholz joined 'Fox & Friends First' to discuss the importance of animal-based proteins for humans as HHS Secretary RFK Jr. pledges to remove toxins from the U.S ...